1. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Issue 10 (October 2022) Authors: Ginde, Adit A.; Paredes, Roger; Murray, Thomas A.; Engen, Nicole; Grandits, Greg; Vekstein, Andrew; Ivey, Noel; Mourad, Ahmad; Sandkovsky, Uriel; Gottlieb, Robert L.; Berhe, Mezgebe; Jain, Mamta K.; Marines-Price, Rubria; Agbor Agbor, Barbine Tchamba; Mateu, Lourdes; España-Cueto, Sergio; Lladós,... Journal: Lancet Issue: Volume 10:Issue 10(2022) Page Start: 972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗